Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder.
Scherrer JF, Salas J, Grucza R, Wilens T, Quinn PD, Sullivan MD, Rossom RC, Wright E, Piper B, Sanchez K, Lapham G.
Scherrer JF, et al.
Drug Alcohol Depend Rep. 2022 Nov 24;5:100122. doi: 10.1016/j.dadr.2022.100122. eCollection 2022 Dec.
Drug Alcohol Depend Rep. 2022.
PMID: 36844161
Free PMC article.